Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
Randomized Experiments01:13

Randomized Experiments

7.0K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.0K
Hazard Ratio01:12

Hazard Ratio

154
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
154
Relative Risk01:12

Relative Risk

208
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
208
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

263
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
263
Cancer Survival Analysis01:21

Cancer Survival Analysis

381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interventions to improve access to sexual and reproductive health services for adolescents living with HIV in sub-Saharan Africa: a scoping review.

BMJ open·2026
Same author

Promoting shared decision-making in colorectal cancer screening in primary care: A cluster randomized controlled trial.

PloS one·2026
Same author

Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: an Evaluation of the COVID-19 Pandemic.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Advancing the Evaluation of Risk-Stratified Colorectal Cancer Screening by Simulating Quantitative Fecal Hemoglobin Concentrations.

MDM policy & practice·2026
Same author

Language-related eligibility criteria in UK randomised trials: a systematic review of extended research reports.

Trials·2026
Same author

Determination of THC and THC-COOH in Dried Capillary Blood Spots and Comparison to Venous Blood of Recreational Cannabis Consumers in a Pilot Study.

Drug testing and analysis·2026

Related Experiment Video

Updated: Jul 17, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.4K

Colorectal Cancer Screening Decision Based on Predicted Risk: Protocol for a Pilot Randomized Controlled Trial.

Ekaterina Plys1, Jean-Luc Bulliard1, Aziz Chaouch1

  • 1Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

JMIR Research Protocols
|September 7, 2023
PubMed
Summary
This summary is machine-generated.

Personalized colorectal cancer (CRC) risk information increases appropriate screening test uptake. This pilot study assessed the feasibility of risk-based CRC screening, aiming to optimize resource allocation and screening benefits.

Keywords:
Switzerlandcolorectal cancer screeningpersonalized screeningrisk communicationscreening behaviorshared decision-making

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

299
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

Related Experiment Videos

Last Updated: Jul 17, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

299
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

Area of Science:

  • Oncology
  • Preventive Medicine
  • Public Health

Background:

  • Colorectal cancer (CRC) screening, including fecal immunochemical tests (FIT) and colonoscopy, reduces incidence and mortality.
  • Individual CRC risk varies significantly, necessitating personalized screening approaches.
  • Current risk-based screening strategies face uncertainties regarding feasibility and efficacy.

Purpose of the Study:

  • To evaluate the impact of communicating individual CRC risk and tailored screening recommendations (FIT or colonoscopy) on participants' test choices.
  • To assess the feasibility of conducting a larger clinical trial on personalized CRC screening outcomes.

Main Methods:

  • A pilot randomized controlled trial involving 880 participants aged 50-69 in Switzerland.
  • Participants were stratified by 15-year CRC risk (low, moderate, high) using the QCancer calculator.
  • The intervention group received personalized risk information and screening recommendations; the control group received standard information.

Main Results:

  • The study anticipates higher appropriate screening uptake in the intervention group compared to the control group.
  • No significant difference in overall screening uptake is expected between the groups.
  • The pilot aims to inform the design of a full-scale randomized controlled trial.

Conclusions:

  • Personalized risk communication can influence appropriate colorectal cancer screening test selection.
  • This research will enhance understanding of large-scale, risk-based CRC screening implementation.
  • Findings may guide optimized CRC screening strategies, balancing risk-benefit and resource utilization.